Trinity Biotech, the Bray-based maker of medical diagnosis equipment, has been told by investors to find a buyer for the company.
Trinity Biotech’s shares collapsed 50 per cent last week after it agreed to withdraw a key heart attack test from trial following concerns by regulators. Several investors in the company, whose shares trade on New York’s Nasdaq stock market, were also critical of its management team. The company said it would take a once-off...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team